Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection FractionMichael E. Nassif, John M. Cox, Benjamin M. Scirica et al.|Circulation|2019Cited by 427
Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failureHorng H. Chen, John C. Burnett, Margaret M. Redfield et al.|Journal of Cardiac Failure|2004Cited by 65
Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart FailureJustin L. Grodin, W.H. Wilson Tang, Susanna R. Stevens et al.|Journal of Cardiac Failure|2015Cited by 62
A Stepwise Pharmacological Care Algorithm for Cardiorenal Syndrome for Acute Heart Failure: Insights from DOSE-AHF, CARRESS-HF, and ROSE-AHFJustin L. Grodin, W.H. Wilson Tang, Susanna R. Stevens et al.|Journal of Cardiac Failure|2014Cited by 1